Science Explorer Back to mapMap
Discussion
Company · Bielefeld · Germany

Apocare Pharma (Germany)

apocarepharma.de/index.php/enROR OpenAlex
Research works
26
▲ 117% vs 2018-21
Citations
274
10.5 per fractional work
Top-10% rate
8.1%
all institutions 10.0%
Open access
32%
world 40%
International
19%
world 18%
Apocare Pharma (Germany)

Not ranked overall: Apocare Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Apocare Pharma (Germany) work in?

In all years, 52% of research at Apocare Pharma (Germany) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (24%), Engineering (6%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 13 fractional works · 51.6% of its workMedicine: 13 fractional works · 49.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 7.7% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 5.3% of its workHematology: 1 fractional works · 4.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.4% of its workEpidemiology: 1 fractional works · 3.1% of its workPathology and Forensic Medicine: 1 fractional works · 2.6% of its workSurgery: 1 fractional works · 2.6% of its workUrology: 1 fractional works · 2.2% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.1% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.0% of its workDermatology: 1 fractional works · 2.0% of its workHepatology: 0 fractional works · 1.8% of its workOncology: 0 fractional works · 1.8% of its workOphthalmology: 0 fractional works · 1.7% of its workGenetics: 0 fractional works · 1.5% of its workInfectious Diseases: 0 fractional works · 1.3% of its workRheumatology: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 1.3% of its workSmall Animals: 0 fractional works · 1.3% of its workHealth Professions: 0 fractional works · 0.8% of its workGeneral Health Professions: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.4% of its workGeneral Dentistry: 0 fractional works · 0.4% of its workLife Sciences: 9 fractional works · 32.7% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 23.6% of its workMolecular Biology: 5 fractional works · 18.0% of its workCancer Research: 0 fractional works · 1.7% of its workGenetics: 0 fractional works · 1.3% of its workBiochemistry: 0 fractional works · 1.3% of its workBiotechnology: 0 fractional works · 0.7% of its workAging: 0 fractional works · 0.7% of its workImmunology and Microbiology: 1 fractional works · 3.9% of its workImmunology: 1 fractional works · 3.9% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.6% of its workToxicology: 0 fractional works · 1.7% of its workPharmaceutical Science: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 0.7% of its workNeuroscience: 0 fractional works · 0.8% of its workBehavioral Neuroscience: 0 fractional works · 0.4% of its workBiological Psychiatry: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workFood Science: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 13.7% of its workEngineering: 2 fractional works · 6.2% of its workBiomedical Engineering: 2 fractional works · 6.2% of its workChemistry: 1 fractional works · 4.9% of its workOrganic Chemistry: 1 fractional works · 4.2% of its workAnalytical Chemistry: 0 fractional works · 0.7% of its workEnvironmental Science: 0 fractional works · 1.2% of its workEcology: 0 fractional works · 0.4% of its workWater Science and Technology: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.7% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workChemical Engineering: 0 fractional works · 0.4% of its workFiltration and Separation: 0 fractional works · 0.4% of its workEnergy: 0 fractional works · 0.3% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 2.0% of its workPsychology: 0 fractional works · 1.3% of its workClinical Psychology: 0 fractional works · 0.8% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.7% of its workEconomics and Econometrics: 0 fractional works · 0.7% of its workALL ITS WORKApocare Pharma(Germany)26fractional works, all years
Life Sciences33%Physical Sciences14%Health Sciences52%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine1349.2%
    2. Veterinary01.3%
    3. Health Professions00.8%
    4. Dentistry00.4%
    1. Biochemistry, Genetics and Molecular Biology623.6%
    2. Immunology and Microbiology13.9%
    3. Pharmacology, Toxicology and Pharmaceutics13.6%
    4. Neuroscience00.8%
    5. Agricultural and Biological Sciences00.8%
    1. Engineering26.2%
    2. Chemistry14.9%
    3. Environmental Science01.2%
    4. Materials Science00.7%
    5. Chemical Engineering00.4%
    6. Energy00.3%
    1. Psychology01.3%
    2. Economics, Econometrics and Finance00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.55× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.02× its world share, 0 worksImmunology and Micro…Neuroscience: 1.94× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 17.83× its world share, 0 worksPharmacology, Toxico…Chemistry: 3.00× its world share, 0 worksChemistryEnergy: 1.28× its world share, 0 worksEnergyEngineering: 0.11× its world share, 0 worksEngineeringEnvironmental Science: 0.60× its world share, 0 worksEnvironmental ScienceHealth Professions: 1.06× its world share, 0 worksHealth ProfessionsMedicine: 1.78× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 1.29× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.8×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics17.83×0 works
  2. Biochemistry, Genetics and Molecular Biology6.55×2 works
  3. Immunology and Microbiology5.02×0 works
  4. Chemistry3.00×0 works
  5. Neuroscience1.94×0 works
  6. Medicine1.78×2 works
  7. Economics, Econometrics and Finance1.29×0 works
  8. Energy1.28×0 works
  9. Health Professions1.06×0 works
  10. Environmental Science0.60×0 works
  11. Engineering0.11×0 works
  12. Agricultural and Biological Sciences0.09×0 works

What are the most cited papers from Apocare Pharma (Germany)?

The most cited paper from Apocare Pharma (Germany) is "Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine to Win Todays Battle Against COVID-19?" (Martin Scholz, Roland Derwand, 2020), with 78 citations. Next come "Photodynamic inactivation of multidrug-resistant Staphylococcus aureus by chlorin e6 and red light (λ = 670 nm)" (54) and "Renal effects of ularitide in patients with decompensated heart failure" (53).

Most cited papers
#PaperReleasedCitations
1 Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine to Win Todays Battle Against COVID-19? Martin Scholz, Roland Derwand · Preprints.org PreprintOpen access 8 Apr 2020 78
2 Photodynamic inactivation of multidrug-resistant Staphylococcus aureus by chlorin e6 and red light (λ = 670 nm) Katrin Winkler, Carole Simon, Melanie Finke et al. · Journal of Photochemistry and Photobiology B Biology 10 Jul 2016 54
3 Renal effects of ularitide in patients with decompensated heart failure Hartmut Lüss, Veselin L. Mitrović, Petar M Seferovic et al. · American Heart Journal 29 May 2008 53
4 ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143 Sara A. Abdel Gaber, Patricia A. J. Muller, Wolfgang Zimmermann et al. · Journal of Photochemistry and Photobiology B Biology 28 Oct 2017 46
5 Chlorin e6 mediated photodynamic inactivation for multidrug resistant Pseudomonas aeruginosa keratitis in mice in vivo Ming‐Feng Wu, Mona Deichelbohrer, Thomas Tschernig et al. · Scientific Reports Open access 15 Mar 2017 38
All 24 most cited papers, with filters and sorting

Which keywords describe research at Apocare Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Reactive Oxygen Species, Photodynamic Therapy, Nanoparticles, Cancer Treatment, Antimicrobial, Drug Discovery, Photosensitizers and Singlet Oxygen.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Reactive Oxygen Species3▲ 22×5 topics
  2. Nanoparticles2▲ 6.8×2 topics
  3. Photodynamic Therapy2▲ 57×2 topics
  4. Cancer Treatment2▲ 29×3 topics
  5. Antimicrobial2▲ 28×2 topics
  6. Oxidative Stress2▲ 3.6×7 topics
  7. Clinical Trials2▲ 9.6×2 topics
  8. Drug Discovery2▲ 15×6 topics
  9. Photosensitizers2▲ 252×1 topic
  10. Singlet Oxygen2▲ 252×1 topic
  11. Adverse Drug Reactions2▲ 87×2 topics
  12. Off-Label Drug Use1▲ 142×1 topic
  13. Pediatric Pharmacokinetics1▲ 142×1 topic
  14. Glycosylation1▲ 23×2 topics
  15. Immunotherapy1▲ 7.7×3 topics
  16. Chemotherapy1▲ 6.7×7 topics
  17. Diagnosis1▲ 4.7×6 topics
  18. Epidemiology1◆ 1.13×8 topics
  19. Monoclonal Antibody1▲ 64×2 topics
  20. Treatment1▲ 3.6×6 topics
  21. Anticancer Agents1▲ 16×4 topics
  22. Inflammation1▲ 1.83×6 topics
  23. Medicinal Chemistry1▲ 11×4 topics
  24. Monoclonal Antibodies1▲ 28×2 topics
  25. Therapeutic Antibodies1▲ 31×2 topics

Which research topics does Apocare Pharma (Germany) publish most on?

By volume in 2022-now: Protein Degradation and Inhibitors, Molecular Biology Techniques and Applications, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.

Protein Degradation and Inhibitors: 1 fractional worksMolecular Biology Techniques and Applications: 0 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksLymphoma Diagnosis and T…0Lymphoma Diagnosis and Treatment: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksAtherosclerosis and Cardiovascular Diseases: 0 fractional worksHER2/EGFR in Cancer Rese…0HER2/EGFR in Cancer Research: 0 fractional worksBioactive Compounds and Antitumor Agents: 0 fractional worksMultiple Myeloma Research and Treatments: 0 fractional worksProtein Tyrosine Phospha…0Protein Tyrosine Phosphatases: 0 fractional works
Molecular BiologyGeneticsPathology and Forensic MedicineRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 1 works
  2. 2 Molecular Biology Techniques and Applications Molecular Biology 0 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
  7. 7 HER2/EGFR in Cancer Research Oncology 0 works
  8. 8 Bioactive Compounds and Antitumor Agents Toxicology 0 works
  9. 9 Multiple Myeloma Research and Treatments Hematology 0 works
  10. 10 Protein Tyrosine Phosphatases Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.5%not open67.5%

World: 40% of research is openly available.

with international co-authors19.3%domestic only80.7%

World: 18% is written across borders.

How has Apocare Pharma (Germany)'s research output changed?

Output in 2022-2025 was 117% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Apocare Pharma (Germany) as a percentage of every work published that year, 0.0000081% in 2024.

still counting0.00020%0.00040%Apocare Pharma (Germany)0.000022% in 20251990200020102020

Fractional works of Apocare Pharma (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bielefeld

All research institutions in Bielefeld

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Apocare Pharma (Germany). Posts are plain text and can be reported.